BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 8334623)

  • 1. Dedifferentiated chordoma. Response to aggressive chemotherapy in two cases.
    Fleming GF; Heimann PS; Stephens JK; Simon MA; Ferguson MK; Benjamin RS; Samuels BL
    Cancer; 1993 Aug; 72(3):714-8. PubMed ID: 8334623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary metastatic chordoma improved by platinum-based chemotherapy.
    Lee MH; Kim SR; Jeong JS; Lee EJ; Lee YC
    Lung Cancer; 2012 May; 76(2):255-7. PubMed ID: 22398139
    [TBL] [Abstract][Full Text] [Related]  

  • 3. De novo dedifferentiated chordoma of the sacrum: a case report and review of the literature.
    Chou WC; Hung YS; Lu CH; Yeh KY; Sheu S; Liaw CC
    Chang Gung Med J; 2009; 32(3):330-5. PubMed ID: 19527613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors in the operative management of dedifferentiated sacral chordomas.
    Kayani B; Sewell MD; Hanna SA; Saifuddin A; Aston W; Pollock R; Skinner J; Molloy S; Briggs TW
    Neurosurgery; 2014 Sep; 75(3):269-75; discussion 275. PubMed ID: 24867206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spinal chordomas dedifferentiated to osteosarcoma: a report of two cases and a literature review.
    Kato S; Gasbarrini A; Ghermandi R; Gambarotti M; Bandiera S
    Eur Spine J; 2016 May; 25 Suppl 1():251-6. PubMed ID: 27052403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastatic chordoma: pattern of spread and response to chemotherapy.
    Ashwood N; Hoskin PJ; Saunders MI
    Clin Oncol (R Coll Radiol); 1994; 6(5):341-2. PubMed ID: 7826929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cutaneous metastasis of chordoma.
    Ruiz HA; Goldberg LH; Humphreys TR; Blacklock JB
    Dermatol Surg; 2000 Mar; 26(3):259-62. PubMed ID: 10759805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sacral chordoma: clinical experience of a series of 11 patients over 18 years.
    Lim JBT; Soeharno H; Tan MH
    Eur J Orthop Surg Traumatol; 2019 Jan; 29(1):9-15. PubMed ID: 30066091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastatic dedifferentiated chordoma with elevated beta-hCG: a case report.
    Munshi HG; Merajver SD; Valdez R; Baker LH; Cooney KA
    Am J Clin Oncol; 2002 Jun; 25(3):274-6. PubMed ID: 12040287
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dedifferentiated chordoma arising in irradiated sacral chordoma.
    Ikeda H; Honjo J; Sakurai H; Mitsuhashi N; Fukuda T; Niibe H
    Radiat Med; 1997; 15(2):109-11. PubMed ID: 9192436
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of cetuximab/gefitinib in the therapy of a sacral chordoma.
    Hof H; Welzel T; Debus J
    Onkologie; 2006 Dec; 29(12):572-4. PubMed ID: 17202828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety margins in resection of sacral chordoma: analysis of 18 patients.
    Ahmed AR
    Arch Orthop Trauma Surg; 2009 Apr; 129(4):483-7. PubMed ID: 18568352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fifty-four-month survival in a 3-year-old child presenting with an aggressive metastatic dedifferentiated clival chordoma.
    Kearns C; Kearns C
    BMJ Case Rep; 2016 Jun; 2016():. PubMed ID: 27284102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple cutaneous metastatic chordomas from the sacrum.
    Svoboda RM; Mackay D; Welsch MJ; Anderson BE
    J Am Acad Dermatol; 2012 Jun; 66(6):e246-7. PubMed ID: 22583730
    [No Abstract]   [Full Text] [Related]  

  • 15. Dedifferentiated chordoma--a case report.
    Sahasrabudhe NS; Jadhav MV; Holla VV
    Indian J Pathol Microbiol; 2002 Jul; 45(3):353-4. PubMed ID: 12785185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dedifferentiated Chordoma: Clinicopathologic and Molecular Characteristics With Integrative Analysis.
    Hung YP; Diaz-Perez JA; Cote GM; Wejde J; Schwab JH; Nardi V; Chebib IA; Deshpande V; Selig MK; Bredella MA; Rosenberg AE; Nielsen GP
    Am J Surg Pathol; 2020 Sep; 44(9):1213-1223. PubMed ID: 32427623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical Treatment of Sacral Chordoma: En Bloc Resection with Negative Margins is a Determinant of the Long-Term Outcome.
    Colangeli S; Muratori F; Bettini L; Frenos F; Totti F; D'Arienzo A; Campo FR; Scoccianti G; Beltrami G; Campanacci DA; Capanna R
    Surg Technol Int; 2018 Nov; 33():343-348. PubMed ID: 30204925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dedifferentiated chordoma: a case report.
    Saito A; Hasegawa T; Shimoda T; Toda G; Hirohashi S; Tajima G; Moriya Y
    Jpn J Clin Oncol; 1998 Dec; 28(12):766-71. PubMed ID: 9879297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dedifferentiated chordoma: a report of four cases arising 'de novo'.
    Hanna SA; Tirabosco R; Amin A; Pollock RC; Skinner JA; Cannon SR; Saifuddin A; Briggs TW
    J Bone Joint Surg Br; 2008 May; 90(5):652-6. PubMed ID: 18450635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of risk factors for recurrence after the resection of sacral chordoma combined with embolization.
    Yang H; Zhu L; Ebraheim NA; Liu X; Castillo S; Tang T; Liu J; Cui H
    Spine J; 2009 Dec; 9(12):972-80. PubMed ID: 19800296
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.